跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LEQVIO inclisiran 284 mg /1.5 mL solution for injection in pre-filled syringe - TGA Drug Approval Details
Approvals
/
TGA
/
LEQVIO inclisiran 284 mg /1.5 mL solution for injection in pre-filled syringe
Approved
STANDARD
LEQVIO inclisiran 284 mg /1.5 mL solution for injection in pre-filled syringe
Novartis Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
7eae0ed4c54a12a2
Company
Novartis Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
7eae0ed4c54a12a2
Product Name
LEQVIO inclisiran 284 mg /1.5 mL solution for injection in pre-filled syringe
Artg Id
342250
Artg Name
LEQVIO inclisiran 284 mg /1.5 mL solution for injection in pre-filled syringe
Sponsor
Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date
2021-09-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/e4d04893301dd6c13117cb4530b974cb.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/138f08c1578b3f077645371bf7718124.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
7eae0ed4c54a12a2
Type
Standard
Back to TGA Approvals